Business
Eli Lilly buys Morphic Holding for $3.2 billion
Eli Lilly has agreed to buy biopharmaceutical company Morphic Holding for $3.2 billion in a deal that strengthens the drugmaker’s immunology pipeline.
Eli Lilly has agreed to buy biopharmaceutical company Morphic Holding for $3.2 billion in a deal that strengthens the drugmaker’s immunology pipeline.